
Releases
Erasca Shareholders Face Securities Fraud Class Action Deadline
Investors who incurred significant financial losses in Erasca, Inc. have until August 10, 2026, to seek appointment as lead plaintiff in a pending securities fraud class action. The lawsuit centers on allegations that the company misled shareholders regarding its drug development processes and potential legal liabilities.


























